Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangko… (NCT07512869) | Clinical Trial Compass
RecruitingNot Applicable
Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation Study
Thailand76 participantsStarted 2025-02-17
Plain-language summary
This study evaluates the pre-implementation phase of a host-led harm reduction model for men who have sex with men (MSM) engaging in chemsex in Bangkok, Thailand, focusing on understanding harms, contexts, and needs to develop a tailored intervention.
Who can participate
Age range
18 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* MSM aged ≥18 years
* Able to communicate in Thai
* Specific by group:
* Chemsex hosts: hosted ≥2 times in past 6 months
* Chemsex guests: attended ≥2 times in past 6 months
* CSO / hospital / police staff: working ≥3 months in related roles
* Provide informed consent
Exclusion Criteria:
• Unable to provide informed consent (e.g., under substance influence at consent)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Substance use-related harm assessed by self-administered questionnaire
Timeframe: Baseline (during Exploration phase, prior to model development)
2
Sexual health risk behaviors assessed by self-administered questionnaire
Timeframe: Baseline (during Exploration phase, prior to model development)
3
Depression severity assessed by Patient Health Questionnaire-9 (PHQ-9)
Timeframe: Baseline (during Exploration phase, prior to model development)
4
Anxiety severity assessed by Generalized Anxiety Disorder-7 (GAD-7)
Timeframe: Baseline (during Exploration phase, prior to model development)
Trial details
NCT IDNCT07512869
SponsorInstitute of HIV Research and Innovation Foundation, Thailand